分期双侧丘脑放射外科能否作为不适合手术的医学难治性双侧震颤患者的选择
本研究评估分期双侧伽玛刀丘脑毁损术(GKT)对医学难治性双侧震颤且不适合侵入性手术患者的疗效与风险。11例患者在17年间接受分期双侧GKT,首次GKT后所有患者至少1项Fahn-Tolosa-Marin(FTM)评分改善,3例(27.3%)震颤完全停止且功能完全恢复;第二次GKT后9例至少1项FTM评分改善,2例震颤完全停止且功能完全恢复,无患者出现新发神经或放射学不良反应。作者认为分期双侧GKT为经仔细选择的医学难治性双侧震颤且不适合脑深部电刺激的患者提供了有效缓解且不增加神经并发症风险。
要点
- 首次GKT后所有11例患者至少1项FTM评分改善,3例(27.3%)震颤完全停止且功能完全恢复。
- 第二次GKT后9例患者至少1项FTM评分改善,2例震颤完全停止且功能完全恢复,无新发神经或放射学不良反应。
- 首次和第二次GKT后KPS评分均出现统计学显著改善。
核心结论
- 分期双侧GKT为医学难治性、致残性双侧震颤提供有效缓解,且不增加神经并发症风险。
- 作者认为分期双侧GKT是经仔细选择的医学难治性双侧震颤且不适合脑深部电刺激患者的合适策略。
研究设计与样本
- 单组病例系列,11例患者于1999—2016年17年间接受分期双侧GKT。
- 8例为特发性震颤(ET),2例为帕金森病(PD)相关震颤,1例为多发性硬化(MS)相关震颤。
主要发现
- 首次GKT中位最大剂量140 Gy,经单等中心4 mm准直器照射丘脑腹中间核(VIM)后下部;第二次GKT中位最大剂量130 Gy,经单4 mm等中心照射对侧VIM核。
- 首次GKT后中位末次随访时间35个月(范围11—70个月),所有患者至少1项FTM评分改善,3例(27.3%)FTM震颤、书写、绘图和饮水评分均等于零,无震颤复发或缓解减退,1例出现新发暂时性神经功能缺损(对侧下肢偏瘫)。
- 第二次GKT后中位末次随访时间12个月(范围2—70个月),9例至少1项FTM评分改善,2例震颤完全停止且功能完全恢复,无震颤复发或缓解减退,无新发神经或放射学不良反应。
- 首次和第二次GKT后KPS评分均出现统计学显著改善。
临床怎么用
- 作者认为分期双侧GKT是经仔细选择的医学难治性双侧震颤且不适合脑深部电刺激患者的合适策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE Unilateral Gamma Knife thalamotomy (GKT) is a well-established treatment for patients with medically refractory tremor who are not eligible for invasive procedures due to increased risk of compications. The purpose of this study was to evaluate whether staged bilateral GKT provides benefit with acceptable risk to patients suffering from disabling medically refractory bilateral tremor. METHODS Eleven patients underwent staged bilateral GKT during a 17-year period (1999-2016). Eight patients had essential tremor (ET), 2 had Parkinson's disease (PD)-related tremor, and 1 had multiple-sclerosis (MS)-related tremor. For the first GKT, a median maximum dose of 140 Gy was delivered to the posterior-inferior region of the nucleus ventralis intermedius (VIM) through a single isocenter with 4-mm collimators. Patients who benefitted from unilateral GKT were eligible for a contralateral GKT 1-2 years later (median 22 months). For the second GKT, a median maximum dose of 130 Gy was delivered to the opposite VIM nucleus to a single 4-mm isocenter. The Fahn-Tolosa-Marin (FTM) clinical tremor rating scale was used to score tremor, drawing, and drinking before and after each GKT. The FTM writing score was assessed only for the dominant hand before and after the first GKT. The Karnofsky Performance Status (KPS) was used to assess quality of life and activities of daily living before and after the first and second GKT. RESULTS The median time to last follow-up after the first GKT was 35 months (range 11-70 months). All patients had improvement in at least 1 FTM score after the first GKT. Three patients (27.3%) had tremor arrest and complete restoration of function (noted via FTM tremor, writing, drawing, and drinking scores equaling zero). No patient had tremor recurrence or diminished tremor relief after the first GKT. One patient experienced new temporary neurological deficit (contralateral lower-extremity hemiparesis) from the first GKT. The median time to last follow-up after the second GKT was 12 months (range 2-70 months). Nine patients had improvement in at least 1 FTM score after the second GKT. Two patients had tremor arrest and complete restoration of function. No patient experienced tremor recurrence or diminished tremor relief after the second GKT. No patient experienced new neurological or radiological adverse effect from the second GKT. Statistically significant improvements were noted in the KPS score following the first and second GKT. CONCLUSIONS Staged bilateral GKT provided effective relief for medically refractory, disabling, bilateral tremor without increased risk of neurological complications. It is an appropriate strategy for carefully selected patients with medically refractory bilateral tremor who are not eligible for deep brain stimulation.
引用
- Niranjan A, Raju SS, Monaco EA, et al. Is staged bilateral thalamic radiosurgery an option for otherwise surgically ineligible patients with medically refractory bilateral tremor? J Neurosurg. 2017. PMID: 28387629. doi:10.3171/2016.11.JNS162044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。